Globally, breast cancer is the most frequently diagnosed cancer with over 2.3 million new cases detected in 2020. This is 1 in 8 women developing breast cancer over their lifetime. This leaves researchers wondering if there is a diagnostic tool that can predict breast cancer risk. Specifically, my honors thesis research is looking at the predictive value of DNA methylation as a biomarker for early signs of breast cancer formation. Although my research is still ongoing, the potential outcomes could help transform millions of lives. I have had multiple family members and close family friends pass away from breast cancer. Personally, I feel as though I am contributing to research that could help prevent other families from suffering from losing a loved one.